Prevalence of Non-communicable Diseases Among Individuals with HIV Infection by Antiretroviral Therapy Status in Dar Es Salaam, Tanzania

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Jul 10

PMID 32645054

Citations 14

Authors

Irene Kato

Basil Tumaini

Kisali Pallangyo

Affiliations

Soon will be listed here.

Abstract

Background: Long-term antiretroviral therapy has modified the clinical course of HIV infection to a chronic condition associated with increased risk of developing non-communicable diseases (NCDs). Information is scant, from sub-Saharan Africa, on the prevalence of NCDs and associated factors among individuals on ART.

Methodology: We consecutively enrolled individuals with HIV infection who were ART naïve and those on ART for ≥5 years (LTART) attending health facilities in Dar es Salaam. Participant's blood pressure, anthropometric measurements, and fasting blood glucose were recorded. Participants with impaired fasting blood glucose underwent an oral glucose tolerance test. A venous blood sample was sent to the lab for biochemical tests. Chi-square test was used to compare proportions, Poisson regression with robust standard errors was used to determine associations between variables.

Results: Overall, 612 individuals with HIV infection were enrolled, half of whom were ART naïve. Females comprised 71.9% and 68.0% of participants in the LTART and ART naïve study arms, respectively, p = 0.290. The mean age (±SD) was 44.9 ± 12.7 years and 37.5 ± 11.8 years among LTART and ART naïve participants, respectively, p<0.001. Hypertension was documented in 25.2% in those on LTART compared to 6.9% among ART naïve subjects, p<0.001. Impaired glucose tolerance was found in 22.9% and 4.6% among LTART compared to ART naïve subjects, p<0.001. Diabetes mellitus was detected in 17.0% of those on LTART compared to 3.9% ART naïve participants, p<0.001. Hypercholesterolemia was found in 30.4% of individuals on LTART compared to 16.7% of ART naïve subjects, p<0.001, and hypertriglyceridemia was found in 16.0% of participants on LTART compared to 9.5% of ART naïve, p = 0.015. LTART use, age ≥40 years, history of smoking, and body mass index were independently associated with NCDs.

Conclusion: Hypertension, impaired glucose tolerance, diabetes mellitus, hypercholesterolemia, and hypertriglyceridemia were associated with long-term use of antiretroviral drugs.

Citing Articles

Challenges in managing HIV and non-communicable diseases and health workers' perception regarding integrated management of non-communicable diseases during routine HIV care in South Central Uganda: A qualitative study.

Kasango A, Daama A, Negesa L PLoS One. 2024; 19(8):e0302290.

PMID: 39163354 PMC: 11335126. DOI: 10.1371/journal.pone.0302290.

Patients' and Care Providers' Reported Barriers and Suggestions for Improving HIV Viral Load Testing in Tanzania: A Qualitative Study in Dar es Salaam.

Karoli P, Shayo E, Shayo G, Kiwale Z, Hawkins C, Kaaya S J Int Assoc Provid AIDS Care. 2024; 23:23259582241273385.

PMID: 39161244 PMC: 11368890. DOI: 10.1177/23259582241273385.

Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus.

Mwakyandile T, Shayo G, Sasi P, Mugusi F, Barabona G, Ueno T BMC Infect Dis. 2024; 24(1):630.

PMID: 38914935 PMC: 11197211. DOI: 10.1186/s12879-024-09548-x.

Socio-environmental predictors of diabetes incidence disparities in Tanzania mainland: a comparison of regression models for count data.

Mbwambo S, Mbago M, Rao G BMC Med Res Methodol. 2024; 24(1):75.

PMID: 38532325 PMC: 11340067. DOI: 10.1186/s12874-024-02166-w.

Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis.

Mohammed O, Alemayehu E, Debash H, Belete M, Gedefie A, Tilahun M BMC Infect Dis. 2024; 24(1):27.

PMID: 38166636 PMC: 10763320. DOI: 10.1186/s12879-023-08910-9.

References

Chang S . Smoking and type 2 diabetes mellitus. Diabetes Metab J. 2013; 36(6):399-403. PMC: 3530709. DOI: 10.4093/dmj.2012.36.6.399. View

Peck R, Shedafa R, Kalluvya S, Downs J, Todd J, Suthanthiran M . Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014; 12:125. PMC: 4243281. DOI: 10.1186/s12916-014-0125-2. View

Araujo S, Banon S, Machuca I, Moreno A, Perez-Elias M, Casado J . Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs. Eur J Endocrinol. 2014; 171(5):545-54. DOI: 10.1530/EJE-14-0337. View

Narayan K, Miotti P, Anand N, Kline L, Harmston C, Gulakowski 3rd R . HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings. J Acquir Immune Defic Syndr. 2014; 67 Suppl 1:S2-7. DOI: 10.1097/QAI.0000000000000267. View

Msango L, Downs J, Kalluvya S, Kidenya B, Kabangila R, Johnson Jr W . Renal dysfunction among HIV-infected patients starting antiretroviral therapy. AIDS. 2011; 25(11):1421-5. PMC: 3631352. DOI: 10.1097/QAD.0b013e328348a4b1. View

Levitt N, Peer N, Steyn K, Lombard C, Maartens G, Lambert E . Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors. Diabetes Res Clin Pract. 2016; 119:41-7. DOI: 10.1016/j.diabres.2016.03.012. View

Magodoro I, Esterhuizen T, Chivese T . A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe. BMC Res Notes. 2016; 9:379. PMC: 4969634. DOI: 10.1186/s13104-016-2187-z. View

Gutierrez A, Balasubramanyam A . Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine. 2011; 41(1):1-10. PMC: 3417129. DOI: 10.1007/s12020-011-9565-z. View

van Wijk J, Cabezas M . Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med. 2011; 2012:201027. PMC: 3159991. DOI: 10.1155/2012/201027. View

10.

Duprez D, Neuhaus J, Kuller L, Tracy R, Belloso W, De Wit S . Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012; 7(9):e44454. PMC: 3438173. DOI: 10.1371/journal.pone.0044454. View

11.

Mayosi B, Flisher A, Lalloo U, Sitas F, Tollman S, Bradshaw D . The burden of non-communicable diseases in South Africa. Lancet. 2009; 374(9693):934-47. DOI: 10.1016/S0140-6736(09)61087-4. View

12.

Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T . A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015; 373(9):808-22. DOI: 10.1056/NEJMoa1507198. View

13.

Okafor U, Unuigbe E, Chukwuonye E . Prevalence and clinical and laboratory characteristics of kidney disease in anti-retroviral-naive human immunodeficiency virus-infected patients in South-South Nigeria. Saudi J Kidney Dis Transpl. 2016; 27(1):129-34. DOI: 10.4103/1319-2442.174155. View

14.

Semu H, Zack R, Liu E, Hertzmark E, Spiegelman D, Sztam K . Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2014; 15(6):512-521. PMC: 4481186. DOI: 10.1177/2325957414542574. View

15.

Ungvari Z, Kaley G, de Cabo R, Sonntag W, Csiszar A . Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010; 65(10):1028-41. PMC: 2950814. DOI: 10.1093/gerona/glq113. View

16.

van Zoest R, Wit F, Kooij K, Van Der Valk M, Schouten J, Kootstra N . Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure. Clin Infect Dis. 2016; 63(2):205-13. DOI: 10.1093/cid/ciw285. View

17.

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

18.

Kazooba P, Kasamba I, Mayanja B, Lutaakome J, Namakoola I, Salome T . Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy. Pan Afr Med J. 2017; 27:40. PMC: 5516660. DOI: 10.11604/pamj.2017.27.40.9840. View

19.

Mave V, Erlandson K, Gupte N, Balagopal A, Asmuth D, Campbell T . Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults. J Infect Dis. 2016; 214(1):65-72. PMC: 4907416. DOI: 10.1093/infdis/jiw096. View

20.

Virdis A, Giannarelli C, Neves M, Taddei S, Ghiadoni L . Cigarette smoking and hypertension. Curr Pharm Des. 2010; 16(23):2518-25. DOI: 10.2174/138161210792062920. View